COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

The saga continues: 3 White House experts say hydroxychloroquine ineffective as a COVID-19 treatment

In the last six days, multiple White House experts have all emphasized they don’t support the use of hydroxychloroquine as a treatment option for COVID-19. 

Thumbnail

Updated cardiac imaging recommendations for treating COVID-19 patients

Differentiating between actual signs of a COVID-19 infection and standard cardiac complications can be especially difficult.

Thumbnail

Pfizer CEO: Expecting pharma to fight COVID for free ‘very fanatic and radical’

The head of the largest pharmaceutical company by revenues is pulling no punches defending the profit motive in the fight against COVID-19.

Alien DNA, retractions, whistleblowers and more: The wild saga of hydroxychloroquine and COVID-19 continues

Hydroxychloroquine was once just an ordinary antimalarial medication—and then 2020 and COVID-19 happened. So how did we get here? 

Thumbnail

How social distancing, outdoor temperatures impact the spread of COVID-19

Researchers tracked data related to more than 178 million U.S. residents. Their findings could help with the development of public policies going forward.

COVID lockdown reopening

Major imaging groups launch campaign urging patients to ‘return to care’

Industry advocates such as RSNA and the American College of Radiology are concerned about recent reports of consumers putting off imaging amid fears of contracting COVID-19. 

78% of COVID-19 patients show signs of heart damage after recovery

Cardiac involvement and myocardial inflammation are common in recovered COVID-19 patients, according to a new study published in JAMA Cardiology.

CDC commits to improving COVID-19 disparities with new data-driven strategy

The agency released a document Friday outlining its approach, which also includes more testing, contact tracing, and safely quarantining, isolating and treating minorities at risk.